GlaxoSmithKline Manufacturing S.P.A. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

GlaxoSmithKline Manufacturing S.P.A. has 0 FDA recalls, 7 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "GlaxoSmithKline Manufacturing S.P.A." is on file.

What these totals cover: FDA records filed under the name "GlaxoSmithKline Manufacturing S.P.A." and its spelling variant "Glaxosmithkline Manufacturing". Records filed under related names are not included; see Related names.

Latest recall
D-0544-2024 · May 17, 2024 · filed under Glaxosmithkline
Latest inspection
Oct 26, 2023 · VAI

Newer recall under related name Glaxosmithkline: May 17, 2024, D-0544-2024.

Reviewing GlaxoSmithKline Manufacturing S.P.A. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check GlaxoSmithKline Manufacturing S.P.A. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections7Nov 14, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

GlaxoSmithKline Manufacturing S.P.A.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

GlaxoSmithKline Manufacturing S.P.A.: FDA inspections per year 2017: 1 inspections120172018: 0 inspections020182019: 0 inspections020192020: 0 inspections020202021: 0 inspections020212022: 0 inspections020222023: 1 inspections120232024: 0 inspections020242025: 0 inspections020252026: 0 inspections02026
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202310000
202200000
202100000
202000000
201900000
201800000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Recent FDA inspections

7 inspections from Jun 28, 2011 to Oct 26, 2023.

DateSiteProductClassificationFEI
Oct 26, 2023Torrile, ItalyDrugsVoluntary Action Indicated (VAI)3002807114
Sep 29, 2017Torrile, ItalyDrugsVoluntary Action Indicated (VAI)3002807114
Jul 22, 2016Torrile, ItalyDrugsNo Action Indicated (NAI)3002807114
May 27, 2015Torrile, ItalyDrugsVoluntary Action Indicated (VAI)3002807114
Jul 10, 2013Torrile, ItalyDrugsNo Action Indicated (NAI)3002807114
Sep 21, 2012Torrile, ItalyDrugsNo Action Indicated (NAI)3002807114
Jun 28, 2011Torrile, ItalyDrugsNo Action Indicated (NAI)3002807114
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3002807114Torrile, Italy7Oct 26, 2023

GlaxoSmithKline Manufacturing S.P.A. and the FDA: common questions

Has GlaxoSmithKline Manufacturing S.P.A. received an FDA warning letter?

No FDA warning letter addressed to the name "GlaxoSmithKline Manufacturing S.P.A." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has GlaxoSmithKline Manufacturing S.P.A. received an FDA Form 483?

FDA has not published a Form 483 for "GlaxoSmithKline Manufacturing S.P.A." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect GlaxoSmithKline Manufacturing S.P.A.?

The most recent FDA inspection on file ended Oct 26, 2023 at Torrile, Italy and was classified VAI. FDA has 7 inspections of GlaxoSmithKline Manufacturing S.P.A. on file.

Need more than this page shows? Ask about GlaxoSmithKline Manufacturing S.P.A. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.